Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

9.1K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.1K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

339
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
339
Clinical Trials01:16

Clinical Trials

11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

508
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
508
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

312
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
312
Blinding01:11

Blinding

4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same author

CT Perfusion Blood Flow Provides an Early Response Marker for Progression-free Survival in a Prospective Randomized Clinical Trial of Metastatic Renal Cell Carcinoma.

Technology in cancer research & treatment·2026
Same author

Unilateral biportal endoscopy versus percutaneous endoscopic lumbar discectomy for far lateral disc herniation: a comparative study of clinical efficacy and learning curves.

BMC musculoskeletal disorders·2026
Same author

Endoscopic posterior cervical canal decompression versus laminoplasty for two-level cervical spondylotic myelopathy: clinical outcomes and finite element analysis.

Journal of orthopaedic surgery and research·2026
Same author

Genome-wide identification of the <i>SKP1</i> gene family in goji (<i>Lycium barbarum</i>) and expression analysis of <i>LbSKP1-14</i> related to self-incompatibility recognition.

Physiology and molecular biology of plants : an international journal of functional plant biology·2026
Same author

Robust CATE estimation using novel ensemble methods.

Journal of biopharmaceutical statistics·2026

Related Experiment Video

Updated: Mar 3, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K

Combining Non-randomized and Randomized Data in Clinical Trials Using Commensurate Priors.

Hong Zhao1, Brian P Hobbs2, Haijun Ma3

  • 1Division of Biostatistics, University of Minnesota School of Public Health, Minneapolis, MN 55455 USA.

Health Services & Outcomes Research Methodology
|May 2, 2017
PubMed
Summary

Randomized clinical trials (RCTs) are the gold standard but have limitations. This study introduces a Bayesian approach to integrate data from non-randomized studies with RCTs, enhancing HIV/AIDS research by leveraging broader patient populations.

Keywords:
Bayesian analysisMarkov chain Monte Carlo (MCMC)commensurate priorsobservational studies (OSs)propensity score matchingrandomized clinical trials (RCTs)

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Related Experiment Videos

Last Updated: Mar 3, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.4K
A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.7K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Clinical Trials

Background:

  • Randomized clinical trials (RCTs) are ideal but exclude patients unwilling to be randomized.
  • Observational studies (OSs) reflect real-world populations but suffer from selection bias.
  • Integrating OSs with RCTs in research synthesis is challenging due to data limitations.

Purpose of the Study:

  • To develop a method for combining data from RCTs and non-randomized substudies.
  • To account for design discrepancies between different data sources.
  • To improve the synthesis of evidence in therapeutic intervention comparisons.

Main Methods:

  • Utilized data from the FIRST HIV/AIDS drug trial, including randomized and non-randomized substudies.
  • Developed hierarchical Bayesian approaches for simultaneous data integration.
  • Employed a two-step method combining propensity score matching and Bayesian hierarchical modeling.

Main Results:

  • The proposed method successfully integrated data from diverse sources, accounting for design differences.
  • Simulation studies validated the operating characteristics of the developed procedure.
  • Demonstrated the potential for well-designed non-randomized studies to complement RCT data.

Conclusions:

  • A novel Bayesian approach effectively combines RCT and non-randomized study data.
  • This method enhances the utility of observational data in research synthesis.
  • Findings have significant implications for HIV/AIDS research and evidence-based medicine.